Boston Scientific has received the CE Mark and is launching in Europe the Vercise Deep Brain Stimulation (DBS) System for patient’s with Parkinson’s. The Vercise is unique in that it allows physicians to selectively control the electric current delivered through each individual electrode.
The company is also touting the fact that the Vercise is the smallest DBS system available while having the longest battery life of any of the competition.
From the announcement:
The first commercial implant of the Vercise™ DBS System was performed by a team at the University Clinic Wurzburg in Germany that included Prof. Dr. Cordula Matthies, Head of Functional Neurosurgery and Prof. Dr. Jens Volkmann, Director of the Department of Neurology.
“We welcome the Vercise DBS System,” said Prof. Dr. Volkmann. “We believe it represents advancement in DBS technology through flexible and unique programming options. We believe the system gives neurologists the ability to precisely target stimulation based on patient needs.”